Amid ongoing concern that drug and device makers may influence medical practice and research, a new analysis suggests the issue also extends to teaching hospitals, which received a total of $832 million in payments for various activities and arrangements other than research in 2018.
Of 1,281 teaching hospitals, 91% received money from industry for continuing education, royalties, consulting and speaking fees, space rentals, gifts, and food, among other things. In all, nearly 47,000 payments were made and most were related to specific products, although one-fifth of the hospitals received more than 90% of the $832 million.
A total of 529 companies reported making at least one payment to teaching hospitals in 2018 and 93% were based in the U.S. Nearly half made medical devices or supplies, with 25% making drugs or biologics and 27% making a mix of products. More than 58% reported fewer than $100,000 in payments to teaching hospitals, while 60 companies reported more than $1 million in payments.
About the Author Reprints
